Depomed (DEPO) Tops Q3 EPS by 11c on Strong Revenues
Tweet Send to a Friend
Depomed (NASDAQ: DEPO) reports Q3 EPS of $0.03, 11 cents better than the analyst estimate of ($0.08). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
